Abstract
Dendritic cells (DCs) are powerful initiators of the adaptive immune system and their manipulation is seen as a viable approach in the treatment of many human ailments. Our isolation method purifies DCs from mouse lymphoid organs by efficiently removing them from the tissue using collagenase, selecting the light density fraction of cells and then negatively selecting for DCs using a combination of monoclonal antibodies directed against non-DC lineage cells together with anti-rat immunoglobulin-coated magnetic beads. Remaining contaminating cells can be depleted using a combination of specific biotinylated antibodies and anti-biotin-coated magnetic beads, in the case of natural killer (NK) cells, or by FACS gating, during sorting or analysis, in the case of autofluorescent macrophages. The heterogenous DCs can then be separated into various functionally different populations via immunofluorescent labelling and cell sorting. The study of mouse DC populations may enable us to align them to their human counterparts and subsequently to DC populations produced in vitro.
Key words
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Jung, S., Unutmaz, D., Wong, P., Sano, G., De los Santos, K., Sparwasser, T., Wu, S., Vuthoori, S., Ko, K., Zavala, F., Pamer, E.G., Littman, D.R. and Lang, R.A. (2002) In vivo depletion of CD11c+ dendritic cells abrogates priming of CD8+ T cells by exogenous cell-associated antigens. Immunity 17, 211–220.
Liu, C.H., Fan, Y.T., Dias, A., Esper, L., Corn, R.A., Bafica, A., Machado, F.S. and Aliberti, J. (2006) Cutting Edge: Dendritic cells are essential for in vivo IL-12 production and development of resistance against Toxoplasma gondii infection in mice. J. Immunol. 177, 31–35.
Ciavarra, R.P., Stephens, A., Nagy, S., Sekellick, M. and Steel, C. (2006) Evolution of immunological paradigms in a virus model: Are dendritic cells critical for antiviral immunity and viral clearance? J. Immunol. 177, 492–500.
Watanabe, N., Wang, Y.H., Lee, H.K., Ito, T., Cao, W. and Liu, Y.J. (2005) Hassall’s corpuscles instruct dendritic cells to induce CD4+CD25+ regulatory T cells in human thymus. Nature 436, 1181–1185.
Luo, X., Tarbell, K.V., Yang, H., Pothoven, K., Bailey, S.L., Dind, R., Steinman, R.M. and Suthanthiran, M. (2007) Dendritic cells with TGF-β1 differentiate naïve CD4+CD25− T cells into islet-protective Foxp3+ regulatory T cells. Proc. Natl. Acad. Sci. USA 104, 2821–2826.
Yamazaki, S., Iyoda, T., Tarbell, K., Olson, K., Velinzon, K., Inaba, K. and Steinman, R.M. (2003) Direct expansion of functional CD25+CD4+ regulatory T cells by antigen presenting dendritic cells. J. Exp. Med. 198, 235– 247.
Wilson, N.S., El-Sukkari, D., Belz, G.T., Smith, C.M., Steptoe, R.J., Heath, W.R., Shortman, K. and Villadangos, J.A. (2003) Most lymphoid organ dendritic cell types are phenotypically and functionally immature. Blood 102, 2187–2194.
Steinman, R.M. (1991) The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 9, 271–296.
Vremec, D and Shortman, K. (1997) Dendritic cell subtypes in mouse lymphoid organs: cross-correlation of surface markers, changes on incubation and differences between thymus, spleen and lymph nodes. J. Immunol. 159, 565–573.
Shortman, K. and Caux, C. (1997) Dendritic cell development: multiple pathways to natures adjuvant. Stem Cells 15, 409–419.
Shortman, K. and Liu, Y.J. (2002) Mouse and human dendritic cell subtypes. Natl. Rev. Immunol. 2, 151–161.
Vremec, D., Pooley, J., Hochrein, H., Wu, L. and Shortman, K. (2000) CD4 and CD8 expression by dendritic cell subtypes in mouse thymus and spleen. J. Immunol. 164, 2978–2986.
Caminschi, I., Ahmet, F., Heger, K., Brady, J., Nutt, S.L., Vremec, D., Pietersz, S., Lahoud, M.H., Schofield, L., Hansen, D.S., O’Keeffe, M., Smyth, M.J., Bedoui, S., Davey, G.M., Villadangos, J.A., Heath, W.R and Shortman, K. (2007) Putative IKDCs are functionally and developmentally similar to natural killer cells, but not to dendritic cells. J. Exp. Med. 204, 2579–2590.
Vremec, D., O’Keeffe, M., Hochrein, H., Fuchsberger, M., Caminschi, I., Lahoud, M. and Shortman, K. (2007) Production of interferons by dendritic cells, plasmacytoid cells, natural killer cells, and interferon-producing killer dendritic cells. Blood 109, 1165–1173.
Naik, S.H., Metcalf, D., van Nieuwenhuijze, A., Wicks, I., Wu, L., O’Keeffe, M. and Shortman, K. (2006) Intrasplenic steady-state dendritic cell precursors which are distinct from monocytes. Nat. Immunol. 7, 663–671.
O’Keeffe, M., Hochrein, H., Vremec, D., Caminschi, I., Miller, J.L., Anders, E.M., Wu, L., Lahoud, M.H., Henri, S., Scott, B., Hertzog, P., Tatarczuch, L. and Shortman, K. (2002) Mouse plasmacytoid cells: long-lived cells, heterogeneous in surface phenotype and function, that differentiate into CD8+ dendritic cells only after microbial stimulus. J. Exp. Med. 196, 1307–1319.
Asselin-Paturel, C., Brizard, G., Pin, J-J., Briere, F. and Trinchieri, G. (2003) Mouse strain differences in plasmacytoid dendritic cell frequency and function revealed by a novel monoclonal antibody. J. Immunol. 171, 6466–6477.
Toyama-Sorimachi, N., Omatsu, Y., Onoda, A., Tsujimura, Y., Iyoda, T., Kikuchi-Maki, A., Sorimachi, H., Dohi, T., Taki, S., Inaba, K, and Karasuyama, H. (2005) Inhibitory NK receptor Ly49Q is expressed on subsets of dendritic cells in a cellular maturation- and cytokine stimulation-dependent manner. J. Immunol. 174, 4621–4629.
Omatsu, Y., Iyoda, T., Kimura, Y., Maki, A., Ishimori, M., Toyama- Sorimachi, N. and Inaba, K. (2005) Development of murine plasmacytoid dendritic cells defined by increased expression of an inhibitory NK receptor, Ly49Q. J. Immunol. 174, 6657–6662.
Naik, S.H. and Shortman, K. (2007) Steady-state and inflammatory dendritic- cell development. Nat. Rev. Immunol. 7, 19–30.
Hochrein, H., Shortman, K., Vremec, D., Scott, B., Hertzog, P. and O’Keeffe, M. (2001) Differential production of IL-12, IFN-α and IFN-γ by mouse dendritic cell subsets. J. Immunol. 166, 5448–5455.
Pooley, J.L., Heath, W.R. and Shortman, K. (2001) Cutting edge: intravenous soluble antigen is presented to CD4 T cells by CD8− dendritic cells, but cross- presented to CD8 T cells by CD8+ dendritic cells. J. Immunol. 166, 5327–5330.
Proietto, A.I., O’Keeffe, M., Gartlan, K., Wright, M.D., Shortman, K. Wu, L. and Lahoud, M.H. (2004) Differential production of inflammatory chemokines by murine dendritic cell subsets. Immunobiology 209, 163–172.
Naik, S.H., Proietto, A.I., Wilson, N.S., Dakic, A., Schnorrer, P., Fuchsberger, M., Lahoud, M.H., O’Keeffe, M., Shao, Q.X., Chen, W.F., Villadangos, J.A., Shortman, K. and Wu, L. (2005) Cutting edge: generation of splenic CD8+ and CD8− dendritic cell equivalents in Fms-like tyrosine kinase 3 ligand bone marrow cultures. J. Immunol. 174, 6592–6597.
Carter, R.W., Thompson, C., Reid, D. M., Wong, S.Y.C. and Tough, D.F. (2006) Preferential Induction of CD4+ T cell responses through in vivo targeting of antigen to dendritic cell-associated C-Type lectin-1. J. Immunol. 177, 2276–2284.
Villadangos, J.A. and Heath, W.R. (2005) Life cycle, migration and antigen presenting functions of spleen and lymph node dendritic cells: Limitations of the Langerhans cells paradigm. Semin. Immunol. 17, 262–272.
Belz, G.T., Smith, C.M., Kleinert, L., Reading, P., Brooks, A., Shortman, K., Carbone, F.R. and Heath, W.R. (2004) Distinct migrating and nonmigrating dendritic cell populations are involved in MHC class I-restricted antigen presentation after lung infection with virus. Proc. Natl. Acad. Sci. USA 101, 8670–8675.
Henri, S., Vremec, D., Kamath, A., Waithman, J., Williams, S., Benoist, C., Burnham, K., Saeland, S., Handman, E. and Shortman, K. (2001) The dendritic cell populations of mouse lymph nodes. J. Immunol. 167, 741–748.
Bursch, L.S., Wang, L., Igyarto, B., Kissenpfennig, A., Malissen, B., Kaplan, D.H. and Hogquist, K.A. (2007) Identification of a novel population of langerin+ dendritic cells. J. Exp. Med. 204, 3147–3156.
Tacken, P.J., deVries, J.M., Torensma, R. and Figdor, C.G. (2007) Dendritic cell immunotherapy: from ex vivo loading to in vitro targeting. Nat. Rev. Immunol. 7, 790–802.
Corbett, A.J., Caminschi, I., McKenzie, B.S., Brady, J.L., Wright, M.D., Mottram, P.L., Hogarth, P.M., Hodder, A.N., Zhan, Y., Tarlinton, D.M., Shortman, K. and Lew, A.M. (2005) Antigen delivery via two molecules on the CD8− dendritic cell subset induces humoral immunity in the absence of conventional “danger”. Eur. J. Immunol. 35, 2815–2825.
Bonifaz, L., Bonnyay, D., Mahnke, K., Rivera, M., Nussenzweig, M.C. and Steinman, R.M. (2002) Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance. J. Exp. Med. 196, 1627–1638.
Caminschi, I., Proietto, A.I., Ahmet, F., Kitsoulis, S., Teh, J.S., Lo, J.C.Y., Jensen, K., Rizzitelli, A., Wu, L., Vremec, D., Maraskovsky, E., Braley, H., Davey, G., Mottram, P., van de Velde, N., Shizuo, A., Lew, A.M., Wright, M.D., Heath, W.R. Shortman, K. and Lahoud, M.H. (2008) The dendritic cell subtype restricted C-type lectin Clec9A is a target for vaccine enhancement. Blood 112, 3264–3273.
Vandenabeele, S., Hochrein, H., Mavaddat, N., Winkel, K. and Shortman, K. (2001) Human thymus contains 2 distinct dendritic cell populations. Blood 97, 1733–1741.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Humana Press, a part of Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Vremec, D. (2010). The Isolation of Mouse Dendritic Cells from Lymphoid Tissues and the Identification of Dendritic Cell Subtypes by Multiparameter Flow Cytometry. In: Naik, S. (eds) Dendritic Cell Protocols. Methods in Molecular Biology, vol 595. Humana Press. https://doi.org/10.1007/978-1-60761-421-0_14
Download citation
DOI: https://doi.org/10.1007/978-1-60761-421-0_14
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-60761-420-3
Online ISBN: 978-1-60761-421-0
eBook Packages: Springer Protocols